Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Alpha Modus and Insight Acquisition Corp Close Business Combination and Alpha Modus will Begin Trading Under “AMOD” Ticker
-
Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules
-
SEALSQ Announces Pricing of $10.0 Million Registered Direct Offering Priced Above Market Under NASDAQ Rules
-
Eco Wave Power Announces Closing of $3.0 Million Registered Direct Offering to Accelerate Commercial-Scale Wave Energy Deployment
-
AmpliTech Group Announces Pricing of $2.2 Million Registered Direct Offering
-
Crossject announces the pricing of its reserved capital increase and warrants issuance for an aggregate amount of EUR 7.2M
-
Crossject launches reserved capital increase and warrants issuance for an aggregate amount of at least €7m
-
Eco Wave Power Global AB (WAVE) Announces Pricing of $3.0 Million Registered Direct Offering to Propel Commercial-Scale Wave Energy Deployment
-
Eco Wave Power Announces Pricing of $3.0 Million Registered Direct Offering to Propel Commercial-Scale Wave Energy Deployment
-
Microstrategy (MSTR) acquired approximately 21,550 more bitcoins
-
LM Funding America Enters Into Warrant Exercise Transaction for Gross Proceeds of $5.1 Million
-
Trust Stamp (IDAI) Prices 5.56M Share Offering at $0.54/sh
-
Trust Stamp Announces Pricing of $3.0 Million Registered Direct Offering
-
Microstrategy (MSTR) acquired approximately 15,400 bitcoins for approximately $1.5 billion in cash
-
AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering
-
Amplitech Group Inc. (AMPG) Prices $1.6M Offering at $0.92/sh
-
AmpliTech Group Announces Pricing of $1.4 Million Registered Direct Offering, Priced At-The-Market
-
Microstrategy, Inc. (MSTR) acquires approximately 55,500 bitcoins for approximately $5.4 billion in cash
-
Chesapeake Utilities Corporation Announces $100 Million At-The-Market Equity Offering Program
-
Draganfly Announces Closing of US$3.76 Million Registered Direct Offering
-
HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules
-
Draganfly Inc (DPRO) Prices 1.6M Unit Offering at $2.35/sh
-
Draganfly Announces Pricing of US$3.76 Million Registered Direct Offering
-
Microstrategy, Inc. (MSTR) Announces Bitcoin Holdings Update
-
SINTX Technologies Announces Stock Repurchase Program
-
Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States
-
HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights
-
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
-
Damon Motors Inc. Completes Business Combination with Grafiti Holding Inc.
-
Maxim Group Reiterates Hold Rating on Aethlon Medical (AEMD)
-
Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States
-
A SPAC III Acquisition Corp. Announces Closing of $55 Million Initial Public Offering
-
B2i Digital Announced as Marketing Partner for ROTH's 13th Annual Technology Conference
-
B2i Digital Announced as Marketing Partner for ROTH’s 13th Annual Technology Conference
-
Microstrategy, Inc. (MSTR) Announces BTC and ATM Activity
-
MicroStrategy Announces BTC and ATM Activity; Raised $2.03 billion; Purchased 27,200 BTC; Now Holds 279,420 BTC with BTC Yield of 26.4% YTD
-
MacKenzie Realty Capital, Inc. Announces Listing on Nasdaq
-
A SPAC III Acquisition Corp. Announces Pricing of $55 Million Initial Public Offering
-
NioCorp Provides Preliminary Financial Results for the Three Months Ended September 30, 2024
-
NioCorp Announces Closing of Underwritten Public Offering
-
Kazia Therapeutics (KZIA) Granted Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib
-
Kazia Therapeutics Announces Granting of Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma Multiforme
-
NioCorp Announces Pricing of Approximately $6.0 Million Underwritten Public Offering & Concurrent Private Placement of Common Shares and Warrants
-
NioCorp Announces Commencement of Proposed Underwritten Public Offering of Common Shares & Warrants
-
Cullen/Frost Bankers (CFR) PT Raised to $149 at Maxim Group
-
Amazon.com (AMZN) PT Raised to $260 at Maxim Group
-
Apple (AAPL) PT Raised to $215 at Maxim Group
-
Apple offers modest growth outlook after iPhone sales help beat profit expectations
-
SRIVARU (SVMH) Announces Closing of Upsized $6.8 Million Underwritten Public Offering
-
Intelligent Bio Solutions (INBS) Partners with B2i Digital to Amplify Investor Outreach

